kaiser glp 1 coverage Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss MCT2D | 2023 Updates to

Clinical trial data from Retatrutide research and from comparable GLP-1 compound trials consistently shows that participants maintaining 80g+ of protein daily preserved lean mass significantly better than those whose protein intake dropped under caloric suppression

Most users see visible improvements within 23 weeks , with full benefits appearing after 68 weeks of consistent use

The gap between marketing claims and scientific evidence is therefore considerable

Understanding that purging is normal (and often a sign the treatment is working) helps users push through this uncomfortable phase rather than abandoning treatment prematurely